Oruka Therapeutics ORKA
NASDAQ ORKA
$81.44 +2.35 (+2.97%)
As of: Oct 21, 2026 · 10:33 AM EDT

Oruka Therapeutics (ORKA) Non-Current Debt (2024)

Updated

Analysis

Oruka Therapeutics (ORKA) Non-Current Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,128.06 Bn 1,096.64 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.47 Bn 534.00 Bn 17.26 Bn 37.34 Bn
3 AbbVie 504.80 Bn 477.91 Bn 12.70 Bn 62.48 Bn
4 Merck 368.45 Bn 322.83 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.44 Bn 262.43 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.92 Bn 235.60 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.10 Bn 191.50 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.71 Bn 164.91 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 60.50 Bn
10 Oruka Therapeutics 5.12 Bn 3.17 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 24.98 Mn
API Access

Oruka Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ORKA&period=max&api_key=YOUR_API_KEY